The Effects of Tyrosine Kinase Inhibitors (TKIs) in Monotherapy and with Add-on Treatments on Health-related Quality of Life of People with Chronic Myeloid Leukemia: A Systematic Review of Randomized-Controlled Trials.
Antonio E NardiFederica SancassianiVanessa BarruiGoce KalcevVeronica UrasGiulia MeloniLuigi MarongiuGiorgio TamburiniAlberto MaleciLaiana A QuagliatoGiorgio La NasaMauro Giovanni CartaPublished in: Clinical practice and epidemiology in mental health : CP & EMH (2023)
All the included RCTs pointed out significant findings regarding the positive effects of TKIs on HRQoL of people with CML, both when they were used in monotherapy or, notably, with an add-on treatment to enhance TKIs effects.